Year: 2020

A Phase 3, Randomized, Double-blind, Placebo- and Active controlled Study to Evaluate the Efficacy and Safety of TLC599 in Patients with Osteoarthritis of the Knee.

Sponsor:
Taiwan Liposome Company
CRO:
Premier Research
Study ID:
TLC599A3005
Phase:
III